/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Rx/Medicines

Topic

Latest Stories

Final Round
7.27.20, 11:20 AM EDT on neoscope
An Experimental COVID-19 Vaccine Begins its Phase 3 Trial Today
Hidden Risks
7.22.20, 3:57 PM EDT on neoscope
Experimental COVID Vaccines Are Giving People Fevers, Headaches, and More
Take It With You
7.21.20, 5:11 PM EDT on neoscope
Pharma Execs Say They Plan to Profit on COVID-19 Vaccine
Arm And A Lung
6.29.20, 11:34 AM EDT on neoscope
Even With Insurance, the COVID Drug Remdesivir Is Shockingly Expensive
Packaging Problems
6.26.20, 1:55 PM EDT on neoscope
The US Might Not Have Enough Glass Vials To Distribute the Coronavirus Vaccines
Empty Well
6.24.20, 11:40 AM EDT on neoscope
With No Patients At Home, China Outsources COVID Vaccine Trials
Final Round
6.10.20, 12:31 PM EDT on neoscope
Three COVID-19 Vaccines Are Ready For Final Stage of Testing
First Attempt
6.1.20, 4:29 PM EDT on neoscope
Scientists Test First COVID-19 Antibody Treatment on Humans
Public Reluctance
5.27.20, 11:36 AM EDT on neoscope
Only One in Two Americans Say They'd Take a COVID-19 Vaccine
Everyone Gets One!
5.8.20, 9:15 AM EDT on neoscope
Doctors Are Cloning COVID Patients' Antibodies For New Treatment
Finally, Drugs
5.1.20, 5:14 PM EDT on neoscope
FDA Grants Emergency Use of Remdesivir For COVID-19 Patients
Accelerated Timeline
4.29.20, 11:09 AM EDT on neoscope
This COVID-19 Vaccine Could Be Ready by September
  • Previous
  • 1
  • ...
  • 16
  • 17
  • 18
  • 19
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.